The role of mineralocorticoid receptor function in treatment-resistant depression

The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary–adrenal activity in humans with psychotic major depression

(2012) Anna Lembke et al.   PSYCHONEUROENDOCRINOLOGY

A Randomized Trial on Mineralocorticoid Receptor Blockade in Men: Effects on Stress Responses, Selective Attention and Memory

(2011) Sandra Cornelisse et al.   NEUROPSYCHOPHARMACOLOGY

Rapid Glucocorticoid Receptor-Mediated Inhibition of Hypothalamic-Pituitary-Adrenal Ultradian Activity in Healthy Males

(2010) G. M. Russell et al.   JOURNAL OF NEUROSCIENCE

The prednisolone suppression test in depression: Dose–response and changes with antidepressant treatment

(2010) Mario F. Juruena et al.   PSYCHONEUROENDOCRINOLOGY

Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance

(2009) Mario F. Juruena et al.   BRITISH JOURNAL OF PSYCHIATRY

Modulation of the mineralocorticoid receptor as add-on treatment in depression: A randomized, double-blind, placebo-controlled proof-of-concept study

(2009) Christian Otte et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The ratio of cortisol/DHEA in treatment resistant depression

(2008) Kalypso Markopoulou et al.   PSYCHONEUROENDOCRINOLOGY

The coming out of the brain mineralocorticoid receptor

(2007) Marian Joëls et al.   TRENDS IN NEUROSCIENCES